日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An initiative using informatics to facilitate clinical research planning and recruitment in the VA health care system

一项利用信息技术促进退伍军人医疗保健系统临床研究规划和招募的计划

Velarde, Kandi E; Romesser, Jennifer M; Johnson, Marcus R; Clegg, Daniel O; Efimova, Olga; Oostema, Steven J; Scehnet, Jeffrey S; DuVall, Scott L; Huang, Grant D

KSHV-induced notch components render endothelial and mural cell characteristics and cell survival

KSHV 诱导的 Notch 成分导致内皮细胞和壁细胞特征以及细胞存活率

Ren Liu, Xiuqing Li, Anil Tulpule, Yue Zhou, Jeffrey S Scehnet, Shaobing Zhang, Jong-Soo Lee, Preet M Chaudhary, Jae Jung, Parkash S Gill

Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth

新型 EphB4 单克隆抗体调节血管生成并抑制肿瘤生长

Valery Krasnoperov, S Ram Kumar, Eric Ley, Xiuqing Li, Jeffrey Scehnet, Ren Liu, Sergey Zozulya, Parkash S Gill

Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion.

抑制 Dll4 介导的信号传导会诱导未成熟血管增殖,导致组织灌注不良

Scehnet Jeffrey S, Jiang Weidong, Kumar S Ram, Krasnoperov Valery, Trindade Alexandre, Benedito Rui, Djokovic Dusan, Borges Cristina, Ley Eric J, Duarte Antonio, Gill Parkash S

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome

受体酪氨酸激酶 EphB4 在卵巢癌中过度表达,提供生存信号并预测不良预后

S R Kumar, R Masood, W A Spannuth, J Singh, J Scehnet, G Kleiber, N Jennings, M Deavers, V Krasnoperov, L Dubeau, F A Weaver, A K Sood, P S Gill

Receptor tyrosine kinase EphB4 is a survival factor in breast cancer

受体酪氨酸激酶 EphB4 是乳腺癌的生存因子

S Ram Kumar, Jasbir Singh, Guangbin Xia, Valery Krasnoperov, Loubna Hassanieh, Eric J Ley, Jeffrey Scehnet, Neil G Kumar, Debra Hawes, Michael F Press, Fred A Weaver, Parkash S Gill

Evo-Devo of amniote integuments and appendages

羊膜动物外皮和附肢的进化发育

Ping Wu, Lianhai Hou, Maksim Plikus, Michael Hughes, Jeffrey Scehnet, Sanong Suksaweang, Randall Widelitz, Ting-Xin Jiang, Cheng-Ming Chuong